Acta Scientific Clinical Case Reports

Review Article Volume 1 Issue 7

Coronary Intervention in a Tertiary Care Centre in North Eastern India during Covid-19 Pandemic- Protocol and Management

Tony Ete1, Arun Kumar2, Vanlalmalsawmdawngliana Fanai2, Vijay Noel Nongpiur3, Amethyst Bamon2, Shakeel Ahamad Khan2, Utpal Kumar2, Tejvir Grewal2 and Animesh Mishra4*

1Assistant Professor, Department of Cardiology, North Eastern Indira Gandhi Regional Institute of Health and Medical Sciences, Shillong, Meghalaya, India
2Senior Resident Doctor, Department of Cardiology, North Eastern Indira Gandhi Regional Institute of Health and Medical Sciences, Shillong, Meghalaya, India
3Nodal Officer (COVID-19), Assistant Professor, Department of General Medicine, North Eastern Indira Gandhi Regional Institute of Health and Medical Sciences, Shillong, Meghalaya, India
4Professor and HOD, Department of Cardiology, North Eastern Indira Gandhi Regional Institute of Health and Medical Sciences, Shillong, Meghalaya, India

*Corresponding Author: Animesh Mishra, Professor and HOD, Department of Cardiology, North Eastern Indira Gandhi Regional Institute of Health and Medical Sciences, Shillong, Meghalaya, India.

Received: July 03, 2020; Published: July 17, 2020

×

Abstract

 Given the novel nature of COVID-19, there is currently no proven treatment beyond supportive care, but robust public health interventions have been introduced internationally to curtail disease transmission, minimize the burden on healthcare systems and protect vulnerable populations, including elderly people and those with existing medical comorbidities. Though coronavirus primarily affects respiratory system, cardiovascular complications such as myocarditis, acute coronary syndrome, exacerbations of heart failure and arrhythmia are not unknown. The general management of acute coronary syndromes (ACS) are well defined in AHA/ACC and European guidelines, but guidelines in the management of ACS in COVID-19 suspected or positive patients are scarce. At the same time, there is an urgent need to manage cardiovascular emergencies with appropriate standards of care and dedicated preventive measures. We present here the protocol dedicated to ACS patients adopted in our centre since March 13, 2020 and our initial experience in the management of ACS patients during the first 3 months of its implementation.

Keywords: COVID-19; Acute Coronary Syndromes (ACS)

×

References

  1. World Health Organization. “Pneumonia of unknown cause - China” (2020).
  2. Ete T., et al. "Disease, Drugs and Dilemma: A Review of Cardiovascular Implications of Novel COVID-19”. Clinical Infection and Immunity2 (2020): 25-30.
  3. Driggin E., et al. "Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the COVID-19 Pandemic”. Journal of the American College of Cardiology 18 (2020): 2352-2371.
  4. Wang D., et al. "Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China”. Journal of the American Medical Association11 (2020): 1061-1069.
  5. Zhou F., et al. "Clinical course and risk factors for mortality of adult in patients with COVID-19 in Wuhan, China: a retrospective cohort study”. Lancet 10229 (2020): 1054-1062.
  6. Li B., et al. "Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China”. Clinical Research in Cardiology 5 (2020): 531-538.
  7. Chen T., et al. "Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study”. British Medical Journal 368 (2020): m1091.
  8. De Filippo O., et al. "Reduced Rate of Hospital Admissions for ACS during Covid-19 Outbreak in Northern Italy”. New England Journal of Medicine 1 (2020): 88-89.
  9. Wang D., et al. "Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China”. Journal of the American Medical Association11 (2020): 1061-1069.
  10. Duane S Pinto., et al. “Coronavirus disease 2019 (COVID-19): Myocardial infarction and other coronary artery disease issues”. UpToDate (2020).
  11. Zhi-Cheng Jing., et al. “COVID-19 & AMI Committee of Peking Union Medical College Hospital Recommendations from the Peking Union Medical College Hospital for the management of Acute Myocardial Infarction during the COVID-19 outbreak”. European Heart Journal 31 (2020): ehaa258.
  12. Guha S., et al. “Managing ACS during COVID-19 infection: Do not follow the traditional route”. Indian Heart Journal 2 (2020): 128-130.
  13. F Zhou., et al. “Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study”. Lancet10229 (2020): 1054-1062.
  14. Zhou X., et al. “Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients With COVID-19: Implications from Clinical Features to Pathologic Findings”. Circulation22 (2020): 1736-1738.
  15. Tabaza L., et al. “Robotic-assisted percutaneous coronary intervention in a COVID-19 patient”. Catheterization and Cardiovascular Interventions (2020).
×

Citation

Citation: Animesh Mishra., et al. “Coronary Intervention in a Tertiary Care Centre in North Eastern India during Covid-19 Pandemic- Protocol and Management". Acta Scientific Clinical Case Reports 1.7 (2020): 14-18.




Metrics

Acceptance rate30%
Acceptance to publication20-30 days
Impact Factor1.278

Indexed In





News and Events


  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is May 25, 2022.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of “Best Article of the Issue”.
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.
  • Contact US